Breast Pain (Mastalgia)
Usually hormonal, rarely dangerous, and often helped by simple things
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
As a clinical topic, the core facts are well established: cyclical mastalgia affects about two-thirds of cases and pain alone carries a positive predictive value under 3 percent for breast cancer, so reassurance and a well-fitted supportive bra are first-line, with topical NSAIDs (diclofenac, piroxicam) the best-supported active option. Evidence for individual remedies is honestly mixed: a 2021 systematic review and meta-analysis of 5 RCTs (525 women) found evening primrose oil no better than placebo (SMD -0.37, 95 percent CI -0.76 to 0.03, high-quality GRADE evidence), while a 2019 Vitex agnus-castus meta-analysis and earlier placebo-controlled RCT show only modest benefit; danazol and tamoxifen work but are reserved for severe refractory pain because of their side-effect and thrombosis profiles.
Reference only. Not medical advice.
What can go wrong
While pain alone is rarely cancer, a new lump, skin change, or nipple discharge should always be checked. Breast changes that worry you deserve evaluation rather than reassurance from a website.
This is something to take to a clinician. The Atlas can tell you what is known about breast pain (mastalgia) in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Breast pain is extremely common and is far more often hormonal than a sign of anything serious, and several low-risk approaches, including chaste tree, have reasonable evidence.
How it works
Cyclical pain follows the hormonal swings of the menstrual cycle, which change the fluid and tissue in the breast. Noncyclical pain can come from the chest wall, large breast size, certain medications, or, rarely, other conditions. Pain alone is an uncommon presentation of breast cancer.
Safety in detail
Most breast pain is benign, but a new focal lump, unilateral persistent or worsening pain, skin changes such as dimpling or redness, or bloody or spontaneous nipple discharge should be evaluated by a clinician rather than self-managed, and warrant imaging even when pain is the leading complaint. Evening primrose oil is safe but not effective, so it should not delay care for a red-flag finding. Chaste tree may interact with dopaminergic and hormonal medications and is generally avoided in pregnancy and hormone-sensitive conditions; danazol and tamoxifen are reserved for severe refractory pain because of androgenic and thromboembolic risks.
What people get wrong
Often saidBreast pain usually means cancer.
ActuallyPain by itself is an uncommon sign of breast cancer, and most breast pain is hormonal.
Often saidNothing helps breast pain except medication.
ActuallySupport, reassurance, and in some cases chaste tree help many women, often without prescription treatment.
Who profits, and who pushes back
Breast-care guidelines
Reassure that most breast pain is benign while advising evaluation of lumps and other changes.
Chaste tree researchers
Report modest benefit for cyclical breast pain in several trials, with more research still needed.
Where the research comes from
Most of the published research on this comes from one place. 90% of it is from Global. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Global | 90% |
How we got here
Cyclical breast pain has been recognized across medical traditions, and herbal remedies for it appear widely, including chaste tree (Vitex agnus-castus) in the Mediterranean world, where it was used for women's complaints as far back as ancient Greece. Twentieth-century breast clinics formalized the split between cyclical mastalgia, tied to the menstrual cycle, and noncyclical pain, and later recognized that much pain referred to breast clinics is actually extra-mammary chest-wall pain. Understanding has shifted care away from routine drug treatment and toward reassurance and low-risk measures, since pain alone is now known to be an uncommon presentation of cancer.
Treated for centuries with herbs like chaste tree and with simple support, breast pain is now understood as usually hormonal, which has shifted care toward reassurance and low-risk measures.
- AntiquityChaste tree used for women's complaints in the Mediterranean
- 20th centuryCyclical and noncyclical pain distinguished
- 2000s-2020sTrials support chaste tree; reassurance emphasized
How it is understood
Most breast pain is cyclical, rising before a period and easing after, and reflects normal hormonal changes rather than disease. It is one of the most common reasons women seek breast evaluation, and reassurance is often the most important treatment.
At a glance
- Most common type
- Cyclical, tied to the period
- Traditional remedy
- Chaste tree (Vitex)
- Pain alone as cancer sign
- Uncommon
- Simple first step
- A well-fitted supportive bra
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Breast Pain (Mastalgia). A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
Cyclical mastalgia is about two-thirds of cases and noncyclical about one-third; extra-mammary chest-wall pain is a common referred cause; topical NSAIDs (diclofenac, piroxicam) are first-line; evening primrose oil has no proven efficacy versus placebo; tamoxifen has the most efficacy evidence but carries thrombosis risk; pain alone has a positive predictive value under 3 percent for cancer.
Breast pain: assessment, management, and referral criteria (review, PMC7384817)
Meta-analysis of 5 RCTs (525 women) found evening primrose oil no better than placebo for mastalgia pain (SMD -0.37, 95 percent CI -0.76 to 0.03, p=0.070; high-quality GRADE), and no different from topical NSAIDs, danazol, or vitamin E.
Systematic review and meta-analysis (25 studies, 17 RCTs plus 8 nonrandomized trials) found Vitex agnus-castus reduced breast-pain intensity and lowered elevated prolactin in reproductive-age women with cyclic mastalgia, indicating a modest real effect.
Placebo-controlled, randomized, double-blind study of a Vitex agnus-castus solution: after one and two cycles, mean pain decrease was 21.4 mm and 33.7 mm with extract versus 10.6 mm and 20.3 mm with placebo, significantly greater with the extract.
Meta-analysis of randomized trials evaluating mastalgia treatments (danazol, tamoxifen, bromocriptine, evening primrose oil and others), confirming danazol and tamoxifen produce significant pain reduction while EPO does not, supporting a reserved role for the hormonal agents.
Evidence-based management of Mastalgia: a meta-analysis of randomised trials (PubMed 17509880)
Imaging is not recommended for cyclical mastalgia with a normal physical exam because this pain is not associated with malignancy; imaging and referral are directed by a focal or new lump, skin changes, bloody nipple discharge, or a unilateral persistent area rather than by pain alone.
Systematic review of understanding and management of mastalgia, supporting classification into cyclical, noncyclical, and extra-mammary pain and a stepwise approach that begins with reassurance and support before drug therapy.
A systematic review of current understanding and management of mastalgia (PubMed 25177120)
Randomized controlled trial in 159 women found Vitex agnus and flaxseed each significantly improved cyclic breast pain over the first and second months versus control, adding trial-level support for a modest herbal effect.
Educational review of breast pain reinforcing that most mastalgia is benign, that evaluation is driven by focal or associated findings, and that skin change, nipple discharge, or a discrete lump are the features prompting imaging.
An Image-Rich Educational Review of Breast Pain (PMC11129617)